Liothyronine Sodium T3

NOVA-T3 Tablets by NovaTech Sciences contain pharmaceutical-grade Liothyronine Sodium (CAS 55-06-1), a synthetic form of the naturally occurring thyroid hormone triiodothyronine (T3). Liothyronine plays a critical role in regulating metabolism, energy production, and endocrine function throughout the body. The compound is globally identified through CAS 55-06-1, ensuring chemical authenticity, traceability, and pharmaceutical standardization within international healthcare markets.

NovaTech Sciences manufactures Liothyronine Sodium CAS 55-06-1 under strict pharmaceutical quality control protocols designed to maintain compound purity, formulation consistency, and reliable global distribution.

Liothyronine Sodium is a synthetic thyroid hormone identical to the active hormone triiodothyronine (T3) produced naturally by the thyroid gland. Registered under CAS 55-06-1, Liothyronine Sodium is used in thyroid hormone replacement therapy when the body cannot produce adequate thyroid hormones.

The CAS registry number 55-06-1 acts as the internationally recognized chemical identifier for Liothyronine Sodium. This identifier guarantees accurate compound verification and regulatory transparency across pharmaceutical manufacturing and supply chains.

Liothyronine Sodium (CAS 55-06-1) works by replacing or supplementing the body's natural T3 hormone. Once absorbed, it directly influences cellular metabolism and regulates multiple physiological processes.

Unlike thyroxine (T4), which must be converted into T3 within the body, Liothyronine already represents the active hormone form, allowing it to act more rapidly within tissues.

Each batch of Liothyronine Sodium CAS 55-06-1 undergoes rigorous analytical testing to confirm chemical identity, purity verification, and dosage accuracy.

NovaTech Sciences operates as a trusted manufacturer, supplier, and exporter of pharmaceutical-grade endocrine medications for global markets. By clearly specifying CAS 55-06-1, NOVA-T3 tablets maintain compound authenticity and regulatory transparency.

These strict processes ensure Liothyronine Sodium tablets meet the quality standards expected by international pharmaceutical distributors and healthcare supply chains.

NovaTech Sciences prioritizes pharmaceutical precision, regulatory compliance, and product reliability. NOVA-T3 tablets containing Liothyronine Sodium CAS 55-06-1 are manufactured using advanced pharmaceutical technologies designed to maintain consistent therapeutic performance.

For pharmaceutical distributors and healthcare suppliers seeking a dependable source of Liothyronine Sodium (CAS 55-06-1), NOVA-T3 Tablets by NovaTech Sciences provide verified compound identity, pharmaceutical manufacturing excellence, and reliable global supply. Supported by strict quality assurance systems, Liothyronine Sodium CAS 55-06-1 remains a recognized thyroid hormone replacement compound associated with metabolic regulation, endocrine balance, and thyroid health support.